نتایج جستجو برای: fasn

تعداد نتایج: 956  

2017
Ye Jiang Xiaofan Yin Liang Wu Qiang Qin Jun Xu

The correlation between mitogen-activated protein kinase (MAPK)/P53 signaling-dependent fatty acid synthase (FASN) expression and bone tumors was examined in the present study. We established the SH081 bone tumor cell line, which was used to determine the expression of FASN and MAPK/P53 at the mRNA and protein levels in bone tumor cells and normal cells. Compared with the normal cells, the expr...

Journal: :The Journal of biological chemistry 2013
Jianxiu Yu Rong Deng Helen H Zhu Sharon S Zhang Changhong Zhu Marc Montminy Roger Davis Gen-Sheng Feng

The Src-homology 2 (SH2) domain-containing tyrosine phosphatase Shp2 has been known to regulate various signaling pathways triggered by receptor and cytoplasmic tyrosine kinases. Here we describe a novel function of Shp2 in control of lipid metabolism by mediating degradation of fatty acid synthase (FASN). p38-phosphorylated COP1 accumulates in the cytoplasm and subsequently binds FASN through ...

2016
Haiyu Wang Qiulei Xi Guohao Wu

Fatty acid synthase (Fasn) is the key metabolic enzyme that accounts for the terminal catalytic step in fatty acid synthesis, which is hyperactivated in various tumors. In this study, we depicted that Fasn expression was elevated in human colorectal cancer (CRC), which accordingly led to lymphatic and distant metastasis and a more advanced clinical phenotype. Genetic perturbations demonstrated ...

2016
Jingxuan Wang Xiao Zhang Jinming Shi Paul Cao Meimei Wan Qiang Zhang Yunxuan Wang Steven J. Kridel Wennuan Liu Jianfeng Xu Qingyuan Zhang Guangchao Sui

Fatty acid synthase (FASN) is upregulated in breast cancer and correlates with poor prognosis. FASN contributes to mammary oncogenesis and serves as a bona fide target in cancer therapies. MicroRNAs inhibit gene expression through blocking mRNA translation or promoting mRNA degradation by targeting their 3'-UTRs. We identified four microRNAs in two microRNA clusters miR-15a-16-1 and miR-497-195...

Journal: :International journal of clinical and experimental pathology 2014
Xin Hua Long Kai Zhao Guo Mei Zhang Yang Zhou Rong Ping Zhou Zhi Li Liu Zhi Hong Zhang

Elevated expression of fatty acid synthase (FASN) and human epidermal growth factor receptor-2 (HER2) are observed in human osteosarcoma (OS). The aim in this study is to investigate a possible connection between FASN expression and the activity of HER2. The immunohistochemistry staining was conducted on 24 OS specimens from patients, which revealed a significant positive correlation between FA...

Journal: :Journal of the National Cancer Institute 2009
Toshiro Migita Stacey Ruiz Alessandro Fornari Michelangelo Fiorentino Carmen Priolo Giorgia Zadra Fumika Inazuka Chiara Grisanzio Emanuele Palescandolo Eyoung Shin Christopher Fiore Wanling Xie Andrew L Kung Phillip G Febbo Aravind Subramanian Lorelei Mucci Jing Ma Sabina Signoretti Meir Stampfer William C Hahn Stephen Finn Massimo Loda

BACKGROUND Overexpression of the fatty acid synthase (FASN) gene has been implicated in prostate carcinogenesis. We sought to directly assess the oncogenic potential of FASN. METHODS We used immortalized human prostate epithelial cells (iPrECs), androgen receptor-overexpressing iPrECs (AR-iPrEC), and human prostate adenocarcinoma LNCaP cells that stably overexpressed FASN for cell proliferati...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010
Paul L Nguyen Jing Ma Jorge E Chavarro Matthew L Freedman Rosina Lis Giuseppe Fedele Christopher Fiore Weiliang Qiu Michelangelo Fiorentino Stephen Finn Kathryn L Penney Anna Eisenstein Fredrick R Schumacher Lorelei A Mucci Meir J Stampfer Edward Giovannucci Massimo Loda

PURPOSE Fatty acid synthase (FASN) regulates de novo lipogenesis, body weight, and tumor growth. We examined whether common germline single nucleotide polymorphisms (SNPs) in the FASN gene affect prostate cancer (PCa) risk or PCa-specific mortality and whether these effects vary by body mass index (BMI). METHODS In a prospective nested case-control study of 1,331 white patients with PCa and 1...

2015
Richard Ventura Kasia Mordec Joanna Waszczuk Zhaoti Wang Julie Lai Marina Fridlib Douglas Buckley George Kemble Timothy S. Heuer

UNLABELLED Inhibition of de novo palmitate synthesis via fatty acid synthase (FASN) inhibition provides an unproven approach to cancer therapy with a strong biological rationale. FASN expression increases with tumor progression and associates with chemoresistance, tumor metastasis, and diminished patient survival in numerous tumor types. TVB-3166, an orally-available, reversible, potent, and se...

2017
Ariadna Giró-Perafita Ariadna Sarrats Ferran Pérez-Bueno Glòria Oliveras Maria Buxó Joan Brunet Gemma Viñas Teresa Puig Miquel

Triple-Negative Breast Cancer (TNBC) has poor prognosis and no approved targeted therapy. We previously showed that the enzyme fatty acid synthase (FASN) was largely expressed in a small TNBC patients' cohort and its inhibition synergized with cetuximab in TNBC preclinical mouse models. Here, we evaluated FASN and EGFR expression in a cohort of TNBC patients and we study their prognostic role a...

Journal: :Carcinogenesis 2010
Kyeongjin Kim Hye Young Kim Hyun Kook Cho Ki Hyeong Kim JaeHun Cheong

Fatty acid synthase (FASN), a key enzyme that synthesizes long-chain fatty acids, is involved in both normal lipid synthesis and cancer development. Overexpression and increased activity of FASN represents one of the most frequent phenotypic alterations in cancer cells. Multiple growth factors and growth factor receptors have emerged as major contributors to FASN overexpression. However, the ul...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید